Corporate Support
Sitemap

Features

Customer Services

Events

Terms of Use

Singapore
Malaysia

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,200.3
27.3 (0.86%)

 

  • STI Straits Times Index
    3,200.3
    27.3 (0.86%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,587.5
    9.1 (0.58%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,610.7
    -26.8 (-0.09%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,418.9
    -22.4 (-0.65%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,357.8
    26.5 (0.09%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,928.3
    -41.9 (-0.70%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,799.6M
  • Value: 1,479.4M
  • Rise: 165
  • Fall: 169
  • Unch: 435

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol

  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Shen Yao0.008-
Renaissance United0.003+0.001
ESR-REIT0.390-0.020
Sembcorp Marine0.198-0.002
SPH1.520-0.270
Jiutian Chemical0.100+0.001
VCPlus0.032-0.001
Blumont0.005-
MM2 Asia0.063-
YZJ Shipbldg SGD1.530+0.010

World Indices

World Indices
Name Last Change
Nasdaq 13,752.2 +119.4
HSI 28,610.7 -26.8
HSCEI 10,699.0 -57.4
Jakarta 5,928.3 -41.9
Nikkei 225 29,357.8 +26.4
SSE Comp 3,418.9 -22.4
Shanghai A 3,583.5 -23.5
Shanghai B 248.2 -0.4
KOSPI 3,197.2 +18.5

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help

  • Factsheet

  • Print

CYMABAY THERAPEUTICS INC CYMABAY THERAPEUTICS INC
Updated on 07 May 2021 (End of trading day)
Last (USD): 4.170 Change: +0.100 High: 4.310 Remarks: -
Change (%): +2.46 Low: 4.090
Open 4.100 Yesterday's Close 4.07
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 436,606 Cumulative Value
 
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.73951 Trailing EPS (USD) e -0.73951 NAV (USD) b 2.0698
PE a - Trailing PE f - Price / NAV b 2.0147
Dividend (USD) d - Cash In Hand (USD) g 0.4089 Issued & Paid-up Shares c 68,946,100
Dividend Yield (%) d - Price / Cash In Hand g 10.198 Treasury Shares h -
Market Cap (M) 287.505 Enterprise Value (M) 142.926
Piotroski F Score 2 Exchange Code CBAY Par Value ( $ ) n.a.
52 Weeks Volatility (%) 114.29 Free Float (%) 92.4
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 26 Mar 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference CYMABAY THERAPEUTICS INC NASDAQ 287.505 - - 2.0147 -
Industry Biotechnology NASDAQ 2,846.314 106.306 106.381 6.7248 0.618
Local Peer AMGEN INC NASDAQ 146,057.372 20.107 20.615 15.6479 2.534
Local Peer GILEAD SCIENCES INC NASDAQ 83,441.160 678.357 277.213 4.4000 4.088
Local Peer MODERNA INC NASDAQ 65,289.367 - - 25.4898 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 55,658.779 20.526 20.151 6.1979 -
Local Peer ILLUMINA INC NASDAQ 56,055.240 85.450 88.977 11.3887 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 52,915.285 15.062 15.062 4.7994 -
Local Peer BIOGEN INC NASDAQ 41,258.092 10.313 13.699 3.8623 -
Local Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 44,369.823 2,561.132 2,560.980 26.4339 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 37,668.268 62.427 55.248 3.0337 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 28,608.023 - - 7.3937 -
Local Peer SEAGEN INC NASDAQ 25,314.227 41.251 38.317 7.3918 -
Local Peer EXACT SCIENCES CORP NASDAQ 17,927.079 - - 6.3493 -
Other Local Peers INCYTE CORPORATION (NASDAQ), BIO-TECHNE CORP (NASDAQ), 10X GENOMICS INC (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), NOVAVAX INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), ACCELERON PHARMA (NASDAQ), EXELIXIS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), RECURSION PHARMACEUTICALS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), ALKERMES PLC (NASDAQ), OLINK HLDG AB SPON ADS EACH REP 1 ORD SHS (NASDAQ), INSMED INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), ARVINAS INC (NASDAQ), VERACYTE INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), ORGANOGENESIS HOLDINGS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), SEER INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), INSTIL BIO INC (NASDAQ), XENCOR INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), FIBROGEN INC (NASDAQ), OCUGEN INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), CYTOKINETICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), IMMUNOVANT INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), BIOATLA INC (NASDAQ), UNIQURE N.V. (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), REGENXBIO INC (NASDAQ), ALLOVIR INC (NASDAQ), EDGEWISE THERAPEUTICS INC (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), VALNEVA SE SPON ADS EACH REPR 2 ORD SHS (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), PRECIGEN INC (NASDAQ), ALECTOR INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), AFFIMED N V (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), OMEROS CORP (NASDAQ), CORTEXYME INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), HUMANIGEN INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), MANNKIND CORPORATION (NASDAQ), VANDA PHARMACE INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), PERSONALIS INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), CURIS INC (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), VAXCYTE INC (NASDAQ), VOR BIOPHARMA INC (NASDAQ), NKARTA INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), VAXART INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), MERUS B V (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), IKENA ONCOLOGY INC (NASDAQ), CHIMERIX INC (NASDAQ), IMMATICS N V (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), AKOYA BIOSCIENCES INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ANAPTYSBIO INC (NASDAQ), EPIZYME INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), VBI VACCINES INC CDA (NASDAQ), ATHIRA PHARMA INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), ARDELYX INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), INHIBRX INC (NASDAQ), IVERIC BIO INC (NASDAQ), KADMON HLDGS INC (NASDAQ), AGENUS INC (NASDAQ), COMPUGEN (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), XBIOTECH INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), VERASTEM INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), ALTIMMUNE INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), ADICET BIO INC (NASDAQ), AKOUOS INC (NASDAQ), SESEN BIO INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), GERON CORP (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), ONCORUS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), VIRACTA THERAPEUTICS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), AVROBIO INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), ATRECA INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), XOMA CORP (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), PORTAGE BIOTECH INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), ATHERSYS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), LAVA THERAPEUTICS NV (NASDAQ), RAIN THERAPEUTICS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), KAMADA LTD (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), TREVENA INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), IMMUNOME INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), CHIASMA INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), CABALETTA BIO INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), NEXTCURE INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), CHEMOMAB THERAPEUTICS LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), MEDICINOVA INC (NASDAQ), MARKER THERAPEUTICS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), SAVARA INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), BIOVIE INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), IMV INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), EQUILLIUM INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), INMUNE BIO INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), SYNLOGIC INC (NASDAQ), EVOGENE LTD (NASDAQ), INFLARX N V (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), CONTRAFECT CORP (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), GAIN THERAPEUTICS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), OTONOMY INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), ORGENESIS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), LONGEVERON INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), ARAVIVE INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), METACRINE INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), PRECIPIO INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), RECRO PHARMA INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), VACCINEX INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), ATYR PHARMA INC (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), ADVAXIS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), BIOCARDIA INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), SOLIGENIX INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), APPLIED DNA SCIENCES INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), PALISADE BIO INC (NASDAQ), GEOVAX LABS INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), HISTOGEN INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), INMED PHARMACEUTICALS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), BRIACELL THERAPEUTICS CORP (NASDAQ), SENESTECH INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ)
Global Peer AMGEN-T HKEx 1,011,789.594 17.959 18.421 13.9429 2.837
Global Peer CSL LTD ASX 124,934.991 39.835 32.828 11.8227 1.069
Global Peer WUXI BIO HKEx 424,178.946 223.510 223.512 17.3972 -
Global Peer BEIGENE HKEx 222,067.547 - - 7.4019 -
Global Peer SINO BIOPHARM HKEx 149,496.915 48.010 48.010 7.5293 0.921
Global Peer ZAI LAB-SB HKEx 112,201.370 - - 12.3748 -
Global Peer JOINN HKEx 36,994.094 104.509 81.946 4.7279 0.241
Global Peer GENSCRIPT BIO HKEx 34,638.744 - - 4.9543 -
Global Peer Lonza SGX 5,940.891 4.560 4.560 0.5844 5.624
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 3,301.939 10.822 8.526 2.1683 -
Other Global Peers KINTOR PHARMA-B (HKEx), NUVATION BIO INC (NYSE), 3SBIO (HKEx), ARCUS BIOSCIENCES INC (NYSE), JACOBIO-B (HKEx), MYOVANT SCIENCES LTD (NYSE), VIVA BIOTECH (HKEx), ALPHAMAB-B (HKEx), HAOHAI BIOTEC (HKEx), JW THERAP-B (HKEx), POLYNOVO LIMITED (ASX), FRONTAGE (HKEx), ASCENTAGE-B (HKEx), JHBP-B (HKEx), IMUGENE LIMITED (ASX), MESOBLAST LTD (ASX), TELIX PHARMACEUTIC (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), ANTEOTECH LIMITED (ASX), DPHARMA (Bursa), ASCLETIS-B (HKEx), LINEAGE CELL THERAPEUTICS INC (NYSE American), SINOMAB BIO-B (HKEx), 22ND CENTURY GROUP INC (NYSE American), ESSEX BIO-TECH (HKEx), OPTHEA LIMITED (ASX), LEE'S PHARM (HKEx), SQZ BIOTECHNOLOGIES CO (NYSE), NEXT SCIENCE LTD (ASX), NANOVIRICIDES INC (NYSE American), IMMUTEP LTD (ASX), CEL-SCI CORP (NYSE American), BIONOMICS LTD (ASX), BIOMX INC (NYSE American), KAZIA THERAPEUTICS LIMITED (ASX), ENZO BIOCHEM INC (NYSE), IBIO INC (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), ARMATA PHARMACEUTICALS INC (NYSE American), AIM IMMUNOTECH INC (NYSE American), LEAF RESOURCES LTD (ASX), PALATIN TECHNOLOGIES INC (NYSE American), UNI-BIO GROUP (HKEx), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), ACTINOGEN MEDICAL LTD (ASX), CYNATA THERAPEUTICS LTD (ASX), CHIMERIC THERAPEUTICS LTD (ASX), GENETIC TECHNOLOGIES (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), REGENT PACIFIC (HKEx), CT ENTERPRISE (HKEx), ALTERITY THERAPEUTICS LIMITED (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), PRESCIENT THERAPEUTICS LIMITED (ASX), INVEX THERAPEUTICS LTD NPV (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), MEMPHASYS LTD (ASX), PATRYS LIMITED (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), Suntar Eco-City (SGX), ORAGENICS INC (NYSE American), BIOTRON (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), RHINOMED LIMITED (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), REGENEUS LTD (ASX), BIOSINO BIO-TEC (HKEx), ADALTA LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), CRYOSITE (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), HOLISTA COLLTECH LIMITED (ASX), NANOLLOSE LTD (ASX), ANATARA LIFESCIENCES LTD (ASX), HAO WEN HLDGS (HKEx), LIVING CELL TECHNOLOGIES (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.160
-3.70 %
10 Days --0.270
-6.08 %
20 Days --0.130
-3.02 %
Medium Term Return 3 Months --1.720
-29.20 %
6 Months --3.680
-46.88 %
1 Year -+2.390
+134.27 %
Long Term Return 2 Years --8.830
-67.92 %
3 Years --6.490
-60.88 %
5 Years -+1.830
+78.21 %
Annualised Return Annualised --
+12.25 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 1.740 - 9.060 Change From 1 Year Low +2.430 % Change From 1 Year Low (%) +139.66
Change From 1 Year High -4.890 % Change From 1 Year High (%) -53.97
2 Years Range 1.210 - 13.320 Change From 2 Years Low +2.960 % Change From 2 Years Low (%) +244.63
Change From 2 Years High -9.150 % Change From 2 Years High (%) -68.69
5 Years Range 1.150 - 15.590 Change From 5 Years Low +3.020 % Change From 5 Years Low (%) +262.61
Change From 5 Years High -11.420 % Change From 5 Years High (%) -73.25
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical need. Its products pipeline include Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
07 May 2021 4.100 4.310 4.090 4.170 436,606 -
06 May 2021 4.230 4.235 3.905 4.070 1,210,120 -
05 May 2021 4.280 4.330 4.150 4.220 950,105 -
04 May 2021 4.360 4.375 4.140 4.270 1,108,402 -
03 May 2021 4.380 4.500 4.320 4.410 587,174 -
30 Apr 2021 4.597 4.670 4.310 4.330 1,147,386 -
29 Apr 2021 4.670 4.725 4.550 4.620 720,747 -
28 Apr 2021 4.530 4.725 4.470 4.670 337,958 -